Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion
Impaired glucagon secretion in patients with diabetes causes hypoglycemia. Here the authors show that therapeutic concentrations of insulin inhibit alpha-cell glucagon secretion by stimulating delta-cell insulin receptor and the release of somatostatin. Blocking somatostatin secretion or action amel...
Auteurs principaux: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Nature Portfolio
2019-01-01
|
Collection: | Nature Communications |
Accès en ligne: | https://doi.org/10.1038/s41467-018-08193-8 |